Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 53

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 53
---
 collection expense3,078 3,663 (585)(16)%9,398 9,884 (486)(5)%Compensation expense6,273 5,743 530 9 %17,906 16,097 1,809 11 %Cytopathology services1,629 1,518 111 7 %4,700 4,386 314 7 %Depreciation and amortization501 360 141 39 %1,487 1,216 271 22 %Other expenses4,326 919 3,407 371 %7,830 3,520 4,310 122 %Allocations3,204 2,939 265 9 %9,989 8,694 1,295 15 %Total$33,777 $29,029 $4,748 16 %$94,444 $82,928 $11,516 14 %Cost of product revenue:        Product costs$1,050 $545 $505 93 %$1,864 $2,436 $(572)(23)%License fees and royalties257 270 (13)(5)%888 1,021 (133)(13)%Depreciation and amortization110 222 (112)(50)%471 659 (188)(29)%Other expenses1,562 528 1,034 196 %2,509 1,713 796 46 %Allocations36 227 (191)(84)%454 481 (27)(6)%Total$3,015 $1,792 $1,223 68 %$6,186 $6,310 $(124)(2)%Cost of biopharmaceutical and other revenue:        Compensation expense$426 $1,424 $(998)(70)%$3,318 $4,958 $(1,640)(33)%License fees and royalties— — — NM— 150 (150)(100)%Depreciation and amortization10 48 (38)(79)%109 172 (63)(37)%Other expenses602 976 (374)(38)%3,009 2,922 87 3 %Allocations53 664 (611)(92)%925 1,560